Month: May 2021

Aino Health announces that they, together with their partner Finla, have signed a customer agreement with a large company within the packaging industry regarding the SaaS solution HealthManager. The initial contract includes 300 employees spread out over all the company’s sites in Finland. The project implementation will finish up during Q2.   This new customer is a part of a larger group consisting of more than 30 000 employees worldwide. “We are very happy to have a customer within the packaging industry and look forward to working with them to improve their employees’ health and engagement going forward”, says Jyrki Eklund, CEO Aino Health. HealthManager is a SaaS solution that supports managers with internal health-related processes and absence management. It also offers reporting and analytic tools to follow key metrics related to...

Novel treatment for osteoporotic fractures  Very dynamic market segment  Launch of a multi-centric study in France and Germany  Worldwide commercialization expected in 2022Éragny-sur-Oise, France, On May 24, 2021 à 8:35 CET – Safe Orthopaedics (FR0013467123 – ALSAF), a holding of the Safe Group (composed of Safe Orthopaedics, a company specializing in the design, manufacturing and marketing of single-use technologies for spinal surgeries, and Safe Medical (Ex-LCI medical), integrated subcontractor for orthopedic medical devices, today announces the CE mark for Sycamore, a new treatment for the management of patients with one or more osteoporotic fractures. Osteoporotic fracture is a global clinical issue. Driven by the aging population and the dynamic lifestyle of those 50 years and older, the number of vertebral fractures has increased...

Luxembourg – 24 May 2021 – Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) today announced the award of a very large(1) contract by Petrobras for the development of the Mero-3 field located approximately 200 kilometres off the coast of the state of Rio de Janeiro, Brazil, at 2,200 metres water depth in the pre-salt Santos basin. The contract scope includes engineering, fabrication, installation and pre-commissioning of 80 kilometres of rigid risers and flowlines for the steel lazy wave production system, 60 kilometres of flexible service lines, 50 kilometres of umbilicals and associated infrastructure, as well as installation of FPSO mooring lines and hook-up. Project management and engineering will commence immediately at Subsea 7’s offices in Rio de Janeiro and Paris. Fabrication of the pipelines will take place at Subsea 7’s spoolbase...

Lochem, 24 May 2021 Update and end of share buy-back programme ForFarmers ForFarmers N.V. (ForFarmers) has repurchased 33.931 shares in the period from 17 May 2021 through 20 May 2021. The shares were repurchased at an average price of €5.37 per share, for a total amount of €182,338. These repurchases were made in accordance with the authorisation granted by the ForFarmers Annual General Meeting of Shareholders on 23 April 2021 to buy back shares. This decision was published the same day, and it was announced that the share buy-back programme would start on 28 April 2021. The total number of shares that has been repurchased to date according to this programme is 190,000 shares, for a total amount of €1,030,400. ForFarmers has herewith completed the share buy-back programme. More information about the share buy-back programme is available...

Geneva, Switzerland, May 24, 2021 – Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that Tim Dyer, Chief Executive Officer, will participate at the virtual Benchmark Company Healthcare House Call Conference on May 26th, 2021 (09:00 – 16:30 EDT) Mr. Dyer will be available for virtual one-on-one meetings throughout the conference. For more information or to schedule a one-on-one meeting with management, please contact your conference representative or James@HaydenIR.com. About Addex Therapeutics:Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators for neurological...

NEW YORK, May 23, 2021 (GLOBE NEWSWIRE) — Digital Asset Monetary Network, Inc. (“DigitalAMN” or the “Company”) (OTCMKTS: DATI), a Public Accelerator-Incubator (“PAI”), announced today, that DigitalAMN has co-founded an international business platform for crowdfunding and other financial services, together with Vincent Petrescu, the CEO of the top-rated (as per Venture Beat—2018 & Crowdwise—2020) FINRA regulated equity crowdfunding portal, TruCrowd, Inc. Carrying the brand’s namesake, TruCrowd Funding, Inc., has been established to build upon the experience and expertise that Mr. Petrescu has gained in the equity crowdfunding space. In carefully curating the growth of a top-rated equity crowdfunding portal owner-operator, TruCrowd Inc. “Mr. Petrescu has the distinct advantage of seeing trends and opportunities in this space,...

SOUTH SAN FRANCISCO, Calif., May 23, 2021 (GLOBE NEWSWIRE) — NGM Biopharmaceuticals, Inc. (Nasdaq: NGM) will host a conference call and live webcast on Monday, May 24, 2021 at 8:30 a.m. ET (5:30 a.m. PT) to discuss topline results from the 24-week Phase 2b ALPINE 2/3 study evaluating 0.3 mg, 1 mg and 3 mg doses of aldafermin versus placebo in patients with non-alcoholic steatohepatitis, or NASH, with stage 2 or 3 liver fibrosis. Conference call and webcast details are as follows: Live Conference CallDomestic Callers: (844) 873-0551International Callers: (602) 563-8472Passcode: 9393531 Live and Archived Webcast                                   For the live or archived webcast, please visit the “Investors & Media” section of NGM’s website at https://ir.ngmbio.com/. The webcast will be archived for 30 days. Archived Conference...